Cord Blood News Volume 4.38 | Sep 27 2012

Meis1 Regulates the Metabolic Phenotype and Oxidant Defense of Hematopoietic Stem Cells
Researchers examined the effect of loss of Meis1 on hematopoietic stem cell function and metabolism. [Blood] Abstract

Adipose Stem Cell-Derived Osteoblasts Sustain the Functionality of Endothelial Progenitors from the Mononuclear Fraction of Umbilical Cord Blood
Results showed how endothelial progenitors present in the mononuclear fraction of umbilical cord blood can be sustained by human adipose-derived stem cell-derived osteoblasts co-culture and contribute to angiogenesis even in an in vivo setting of inflammatory response. [Acta Biomater] Abstract

Paracrine Pro-Angiopoietic Effects of Human Umbilical Cord Blood-Derived Purified CD133+ Cells – Implications for Stem Cell Therapies in Regenerative Medicine
Researchers hypothesized that CD133+ cells secrete several paracrine factors that play a major role in the positive effects observed after treatment and tested supernatants derived from these cells for the presence of such factors. [Stem Cells Dev] Abstract

Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver Fibrosis
Results suggested that exosomes derived from human umbilical cord-mesenchymal stem cells could ameliorate CCl4-induced liver fibrosis by inhibiting epithelial-to-mesenchyme transition and protecting hepatocytes. [Stem Cells Dev] Abstract

Reendothelialization of Human Heart Valve Neoscaffolds Using Umbilical Cord-Derived Endothelial Cells
Researchers aimed to develop tissue engineered heart valves combining human umbilical vein endothelial cells and decellularized human heart valve matrices. [Circ J] Abstract | Full Article

Stem Cell Source-Dependent Reconstitution of FOXP3+ T Cells after Pediatric SCT and the Association with Allo-Reactive Disease
Investigators compared CD4+FOXP3+ T-cell reconstitution after unrelated cord blood, matched unrelated donor and matched sibling donor hematopoietic SCT in children, starting as early as one week after transplantation, and analyzed the association with allo-reactive disease. [Bone Marrow Transplant] Abstract

A Tag-Less Method for Direct Isolation of Human Umbilical Vein Endothelial Cells by Gravitational Field-Flow Fractionation
Researchers proposed a new method for an easy, tag-less and direct isolation of human umbilical vein endothelial cells from raw umbilical cord sample based on the gravitational field-flow fractionation. [Anal Bioanal Chem] Abstract

Human Umbilical Cord Mesenchymal Stem Cells Reduce Systemic Inflammation and Attenuate LPS-Induced Acute Lung Injury in Rats
Scientists investigated whether human umbilical cord-derived mesenchymal stem cells could ameliorate lipopolysaccharide- (LPS-) induced acute lung injury in a rat model. [J Inflamm (Lond)] Abstract | Full Article

Gamida Cell Completes Enrollment for Phase I/II Study of Second Pipeline Product Nicord® for Hematological Malignancies
Gamida Cell announced that it has completed enrollment for a Phase I/II clinical trial of NiCord, the company’s second pipeline product. NiCord is an expanded cell graft derived from an entire unit of umbilical cord blood enriched with stem cells. [Gamida Cell] Press Release

Unigene and Tarix Pharmaceuticals Report Highly Increased Oral Bioavailability of “Peptelligence-Engineered” TXA127
Unigene Laboratories, Inc. and Tarix Pharmaceuticals announced the successful completion of a feasibility study of an oral formulation of TXA127. Tarix is developing TXA127 for multiple therapeutic indications, including enhancement of engraftment following peripheral blood and cord blood stem cell transplantation, reduction in GVHD and mucositis following allogeneic stem cell transplantation, and peripheral vascular disease. [Unigene Laboratories, Inc.] Press Release

National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)

View our events page to see a complete list of events in the cord blood community.

Research Technologist – Media Development (STEMCELL Technologies, Inc.)

Research Technologist – Research and Development (STEMCELL Technologies, Inc.)

Scientific Communications & Publishing Coordinator (STEMCELL Technologies, Inc.)

Quality Control Operations Coordinator (STEMCELL Technologies, Inc.)

Product Manager – Hematopoietic (STEMCELL Technologies, Inc.)

Clinical Lab Scientist – Cord Blood (Cardinal Glennon Children’s Medical Center)

Research Associate – Quality Assurance (University of California)

Postdoctoral Position in Mouse Stem Cell Biology (University of Alabama at Birmingham)

Postdoctoral Fellow in Stem Cells and Cancer (Tsinghua University)

Postdoctoral Position in Mouse Developmental Biology (Lund Stem Cell Center, Lund University)


Recruit Top Talent: Reach more than 55,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Cord Blood News? Click here to submit!

Comments or Suggestions? Email info@connexoncreative.com with your feedback.